thalidomide has been researched along with Cardiac Output, Low in 2 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
Cardiac Output, Low: A state of subnormal or depressed cardiac output at rest or during stress. It is a characteristic of CARDIOVASCULAR DISEASES, including congenital, valvular, rheumatic, hypertensive, coronary, and cardiomyopathic. The serious form of low cardiac output is characterized by marked reduction in STROKE VOLUME, and systemic vasoconstriction resulting in cold, pale, and sometimes cyanotic extremities.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Data about BNP dosage for cardiovascular monitoring of patients with ALA on renal replacement therapy are lacking." | 1.33 | Role of B-type natriuretic peptide in cardiovascular state monitoring in a hemodialysis patient with primary amyloidosis. ( Cantelli, S; Catizone, L; Fabbian, F; Molino, C; Russo, G; Russo, M; Sartori, S; Stabellini, N, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fabbian, F | 1 |
| Stabellini, N | 1 |
| Sartori, S | 1 |
| Molino, C | 1 |
| Russo, G | 1 |
| Russo, M | 1 |
| Cantelli, S | 1 |
| Catizone, L | 1 |
| Aukrust, P | 1 |
| Yndestad, A | 1 |
| Damås, JK | 1 |
| Ueland, T | 1 |
| Øie, E | 1 |
| Gullestad, L | 1 |
1 review available for thalidomide and Cardiac Output, Low
| Article | Year |
|---|---|
Potential mechanisms of benefit with thalidomide in chronic heart failure.
Topics: Animals; Cardiac Output, Low; Fibrosis; Heart Rate; Humans; Immune System; Immunosuppressive Agents; | 2007 |
1 other study available for thalidomide and Cardiac Output, Low
| Article | Year |
|---|---|
Role of B-type natriuretic peptide in cardiovascular state monitoring in a hemodialysis patient with primary amyloidosis.
Topics: Amyloidosis; Anti-Inflammatory Agents; Bicarbonates; Buffers; Cardiac Output, Low; Follow-Up Studies | 2006 |